Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in ECD/AKI Kidney Transplant Recipients
NCT02314312Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Jan 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of everolimus in kidney transplantation (2 arms), sponsored by Mahidol University. Primary endpoint: Mean estimated Glomerular Filtration Rate (CKD-EPI formula) at 12 months. Status: unknown.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02314312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314312.